Phagenyx System
Post-Stroke Dysphagia
Key Facts
About Phagenesis
Phagenesis is a commercial-stage medical device company addressing the significant unmet need of post-stroke dysphagia with its Phagenyx System. The device delivers targeted pharyngeal electrical stimulation (PES) to sensory nerves, promoting neurologic recovery of swallowing function. Backed by over 30 publications and recent inclusion in the AHA/ASA stroke guidelines, the technology has demonstrated in clinical studies the ability to reduce aspiration risk, speed return to oral nutrition, and significantly shorten hospital and ICU stays. The company is positioned to transform post-stroke care by offering an evidence-based, non-disruptive intervention for a condition with high morbidity, mortality, and economic burden.
View full company profile